The burgeoning UK landscape surrounding mind-altering substances is increasingly complex, demanding careful navigation. While therapeutic investigation into compounds like psilocybin and copyright continues to unfold, and patient opportunity via private clinics is growing, the legal framework remains unclear. This presents a distinctive situatio… Read More